Valneva SE VALN
5.52 USD -0.21 (-3.66%)
As ofNov 17, 2026, 12:54 PM EST
5.51 Day range 5.80
4.75 52-week range 12.18
- YTD
- -37.41%
- 1 year
- -37.91%
News
benzinga.com Valneva Reports Five-Year Antibody Persistence for Chikungunya Vaccine Valneva SE (NASDAQ:VALN) reported positive five-year antibody persistence results for its single-dose chikungunya vaccine, IXCHIQ, confirming that the shot delivers lasting immune protection across…
benzinga.com Valneva Reports Five-Year Antibody Persistence for Chikungunya Vaccine Valneva reports 94% of adults sustained antibody protection five years after receiving its single-dose chikungunya shot IXCHIQ.benzinga.com Valneva Says Single-Dose Chikungunya Vaccine IXCHIQ Showed Antibody Persistence Consistent With Prior Results, In Line With Company Expectations, With 94% Seroresponse At Year 5 Across Age Groups 94% of participants maintained seroresponse five years after a single vaccinationComparable antibody persistence observed in older (65+) and younger adultsData further reinforce IXCHIQ®'s…
